Murali Chakinala is a Respiratory physician affiliated with University of Missouri–St. Louis. OpenAlex indexes 193 publications with 5,252 citations (h-index 40).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4921 Parkview Pl
Div Im Pulmonary And Ccm, 8th Fl
Saint Louis, MO 631101032
Telephone
314-454-8917Registry record last updated 15 Apr 2025.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202526 payments$12,706openpaymentsdata.cms.gov ↗
- United Therapeutics CorporationProgram year202518 payments$10,617openpaymentsdata.cms.gov ↗
- Chiesi USA, Inc.Program year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2007–2007 per NIH RePORTER. The latest:
- IMPACT OF COMMUNITY-ACQUIRED RESPIRATORY VIRAL INFECIONS IN LUNG TRANSPLANT
Washington University
FY2007$2,033M01RR000036
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial
The Lancet Respiratory Medicine
2024 - Contemporary Treatment of Pulmonary Arterial Hypertension: A U.S. Perspective
American Journal of Respiratory and Critical Care Medicine
2024 - Pulmonary Hypertension and Anastrozole (PHANTOM): A Randomized, Double-Blind, Placebo-Controlled Trial
American Journal of Respiratory and Critical Care Medicine
2024 - Defining the clinical validity of genes reported to cause pulmonary arterial hypertension
Genetics in Medicine
2023 - Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry
Journal of the American Heart Association
2022
Similar KOLs
Other experts from the same institution or the same specialty.
George Grossberg, MD
University of Missouri–St. Louis
Carla Siegfried, MD
University of Missouri–St. Louis
Mildred Olivier, MD
University of Missouri–St. Louis
Zachary Farhood, MD
University of Missouri–St. Louis
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”